4//SEC Filing
WORLAND STEPHEN T 4
Accession 0001209191-23-029646
CIK 0001828522other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 8:03 AM ET
Size
5.6 KB
Accession
0001209191-23-029646
Insider Transaction Report
Form 4
WORLAND STEPHEN T
DirectorPresident and Chief Executive
Transactions
- Award
Common Stock
2023-05-15$0.46/sh+6,401$2,938→ 227,426 total
Holdings
- 562,339(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
Documents
Issuer
eFFECTOR Therapeutics, Inc.
CIK 0001828522
Entity typeother
Related Parties
1- filerCIK 0001283307
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 8:03 AM ET
- Size
- 5.6 KB